Back
Results - Announcements
Makers Laboratories Ltd consolidated sales up 19.64% on year in Q2FY2026, net profit jumped 29.21%
07-Aug-2026, 02:34
Makers Laboratories Ltd share price gained 1.62% to Rs 165.9 after the company's net profit saw a strong growth of 29.21% to Rs 4.6 crore, while revenue from operations increased 19.64% to Rs 42.77 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.84 lakh crore, gaining 5.32%. It has improved by 0.53% over last one week and moving up by 11.64% in last one month while the market capitalization of Makers Laboratories Ltd has edged up by 11.30% and 5.84% in the same period respectively. Profit before tax (PBT) of Makers Laboratories Ltd stood at Rs 6.29 crore in Q2 FY26, surging by 217.68% year-on-year, and expanding by 32.98% quarter-on-quarter. EBITDA came in at Rs 6 crore, rallying 131.75% YoY and jumping 40.80% sequentially. Total expenses increased by 16.86% to Rs 36.94 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 15.02 crore, soaring by 36.79% YoY, while employee benefits expense was at Rs 4.08 crore, ticking higher by 4.35% YoY. For the TTM ended FY26, revenue from operations improved 16.43% to Rs 140.59 crore, while net profit tanked by 27.96% to Rs 7.86 crore, compared to previous TTM. EBITDA saw a sharp decline of 476% to Rs 13.03 crore, and PBT declined 16.85% to Rs 11.15 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.29 crore in FY26, as against Rs 4.08 crore in FY25. Makers Laboratories Ltd surged by 12.02% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 1.97% during the same period.
Makers Laboratories Ltd share price gained 1.62% to Rs 165.9 after the company's net profit saw a strong growth of 29.21% to Rs 4.6 crore, while revenue from operations increased 19.64% to Rs 42.77 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.84 lakh crore, gaining 5.32%. It has improved by 0.53% over last one week and moving up by 11.64% in last one month while the market capitalization of Makers Laboratories Ltd has edged up by 11.30% and 5.84% in the same period respectively. Profit before tax (PBT) of Makers Laboratories Ltd stood at Rs 6.29 crore in Q2 FY26, surging by 217.68% year-on-year, and expanding by 32.98% quarter-on-quarter. EBITDA came in at Rs 6 crore, rallying 131.75% YoY and jumping 40.80% sequentially. Total expenses increased by 16.86% to Rs 36.94 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 15.02 crore, soaring by 36.79% YoY, while employee benefits expense was at Rs 4.08 crore, ticking higher by 4.35% YoY. For the TTM ended FY26, revenue from operations improved 16.43% to Rs 140.59 crore, while net profit tanked by 27.96% to Rs 7.86 crore, compared to previous TTM. EBITDA saw a sharp decline of 476% to Rs 13.03 crore, and PBT declined 16.85% to Rs 11.15 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.29 crore in FY26, as against Rs 4.08 crore in FY25. Makers Laboratories Ltd surged by 12.02% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 1.97% during the same period.